Moonlake Immunotherapeutics (MLTX)

$18.77 +0.60 (3.30%)
Market Cap 1.21B
Revenue (ttm) 0.00
Net Income (ttm) -118.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.25
Volume 1,983,000
Avg Vol 2,286,326
Day's Range N/A - N/A
Shares Out 64.23M
Stochastic %K 97%
Beta 1.21
Analysts Sell
Price Target $20.41

Company Profile

MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

Industry: Biotechnology
Sector: Healthcare
Phone: 41 415108022
Address:
Dorfstrasse 29, Zug, Switzerland
ezequielsingh_90
ezequielsingh_90 Feb. 23 at 1:42 PM
$MLTX Think big scale, brother! Cutting peak demand 15–20% ain’t small potatoes - it’s structural uplift! 📈💥
0 · Reply
Warren_8
Warren_8 Feb. 23 at 1:39 PM
$MLTX
0 · Reply
ProteinAndProfits
ProteinAndProfits Feb. 23 at 1:39 PM
$MLTX Really appreciate Jorge’s explanation of labels, very interesting
1 · Reply
Ape_Of_WallStreet
Ape_Of_WallStreet Feb. 23 at 1:37 PM
$MLTX moon going to the moon
0 · Reply
Team_Zissou
Team_Zissou Feb. 23 at 1:36 PM
$MLTX Love Jorge specifically calling out the potential criticisms of one or two analysts at more than one point in his presentation. Don’t hold back Jorge, give ‘em hell!
1 · Reply
Cardwizard
Cardwizard Feb. 23 at 1:36 PM
$MLTX good information but nothing in the speech so far on the call that’s causing the stock to spike by any means,, unless Wall Street is just waiting for the bell to ring.
1 · Reply
HOWNOW
HOWNOW Feb. 23 at 1:34 PM
$MLTX 👆✅👍✊
0 · Reply
Bigpapa46
Bigpapa46 Feb. 23 at 1:33 PM
$MLTX Well my feed just crashed lol
1 · Reply
ParadiseProfit
ParadiseProfit Feb. 23 at 1:30 PM
$MLTX $FBIO $AIOS $IPW All low floats are going crazy! IBG could be next it seems!
0 · Reply
navyvet1234
navyvet1234 Feb. 23 at 1:29 PM
$MLTX Don't give up a single share.....be patient and HOLD what you have. It will pay off in spades in the end. Trust the science!!!!
0 · Reply
Latest News on MLTX
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

Feb 10, 2026, 7:00 AM EST - 13 days ago

ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

IMA

MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day

Feb 2, 2026, 8:00 AM EST - 21 days ago

MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day

Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares

Jan 27, 2026, 7:30 AM EST - 27 days ago

Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares

Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering

Jan 23, 2026, 7:30 AM EST - 4 weeks ago

Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering

MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission

Jan 9, 2026, 8:15 AM EST - 6 weeks ago

MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission

MoonLake Says FDA May Allow Skin Drug Filing Without New Trials, Stock Soars

Jan 8, 2026, 2:06 PM EST - 6 weeks ago

MoonLake Says FDA May Allow Skin Drug Filing Without New Trials, Stock Soars

MOONLAKE DECEMBER 15th DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds MoonLake Immunotherapeutics Investors to Contact the Firm

Dec 15, 2025, 10:46 AM EST - 2 months ago

MOONLAKE DECEMBER 15th DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds MoonLake Immunotherapeutics Investors to Contact the Firm

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Dec 11, 2025, 10:08 AM EST - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025

Dec 11, 2025, 8:54 AM EST - 2 months ago

DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025

MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Dec 8, 2025, 1:23 PM EST - 2 months ago

MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Stock Picks From Seeking Alpha's November 2025 New Analysts

Dec 8, 2025, 9:00 AM EST - 2 months ago

Stock Picks From Seeking Alpha's November 2025 New Analysts

ABEV CEG CEPU EAT GLXY GT KOF

MoonLake Immunotherapeutics (MLTX) Investors are Encouraged to Act before the Upcoming December 15 Securities Fraud Deadline – Contact BFA Law if You Lost Money

Dec 5, 2025, 8:18 AM EST - 2 months ago

MoonLake Immunotherapeutics (MLTX) Investors are Encouraged to Act before the Upcoming December 15 Securities Fraud Deadline – Contact BFA Law if You Lost Money

MoonLake's (MLTX) SLK Efficacy Claims Under Scrutiny After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority- Hagens Berman

Dec 5, 2025, 8:06 AM EST - 2 months ago

MoonLake's (MLTX) SLK Efficacy Claims Under Scrutiny After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority- Hagens Berman

MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake's SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority

Dec 4, 2025, 3:01 PM EST - 2 months ago

MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake's SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX

Dec 4, 2025, 9:00 AM EST - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX

MLTX NEWS: MoonLake Immunotherapeutics Sued for Securities Fraud after Stock Plummets 90% -- Investors Notified to Contact BFA Law by December 15 Deadline

Dec 3, 2025, 7:46 AM EST - 2 months ago

MLTX NEWS: MoonLake Immunotherapeutics Sued for Securities Fraud after Stock Plummets 90% -- Investors Notified to Contact BFA Law by December 15 Deadline

Bragar Eagel & Squire, P.C. Urges Investors of Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines

Dec 2, 2025, 5:29 PM EST - 2 months ago

Bragar Eagel & Squire, P.C. Urges Investors of Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines

CPTN

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Dec 1, 2025, 5:52 PM EST - 2 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

MLTX SHAREHOLDERS: MoonLake Immunotherapeutics Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 15

Dec 1, 2025, 3:18 PM EST - 2 months ago

MLTX SHAREHOLDERS: MoonLake Immunotherapeutics Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 15

Voya MidCap Opportunities Strategy Q3 2025 Portfolio Review

Dec 1, 2025, 12:26 PM EST - 2 months ago

Voya MidCap Opportunities Strategy Q3 2025 Portfolio Review

APP FIX KTOS TW VRSK

MLTX LAWSUIT: BFA Law Reminds MoonLake Immunotherapeutics Investors the Company has been Sued for Securities Fraud and to Contact BFA Law by December 15 Deadline

Nov 30, 2025, 7:45 AM EST - 3 months ago

MLTX LAWSUIT: BFA Law Reminds MoonLake Immunotherapeutics Investors the Company has been Sued for Securities Fraud and to Contact BFA Law by December 15 Deadline

MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman

Nov 28, 2025, 5:50 PM EST - 3 months ago

MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman

MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman

Nov 27, 2025, 2:15 PM EST - 3 months ago

MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman

MOONLAKE NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Fraud Allegations after Stock Drops 90%, Investors Urged to Contact BFA Law

Nov 24, 2025, 6:08 AM EST - 3 months ago

MOONLAKE NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Fraud Allegations after Stock Drops 90%, Investors Urged to Contact BFA Law

MoonLake: Ignore The Panic, Catch The Upside

Nov 18, 2025, 12:33 AM EST - 3 months ago

MoonLake: Ignore The Panic, Catch The Upside

MOONLAKE INVESTORS: MoonLake Immunotherapeutics (MLTX) has been Sued for Securities Fraud, Investors are Urged to Contact BFA Law

Nov 14, 2025, 6:08 AM EST - 3 months ago

MOONLAKE INVESTORS: MoonLake Immunotherapeutics (MLTX) has been Sued for Securities Fraud, Investors are Urged to Contact BFA Law

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) DEADLINE ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

Nov 10, 2025, 8:15 AM EST - 3 months ago

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) DEADLINE ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MLTX STOCK NOTICE: MoonLake Immunotherapeutics Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 15 Deadline

Nov 10, 2025, 6:06 AM EST - 3 months ago

MLTX STOCK NOTICE: MoonLake Immunotherapeutics Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 15 Deadline

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering

Nov 5, 2025, 7:11 AM EST - 3 months ago

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering

MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

Nov 5, 2025, 7:00 AM EST - 3 months ago

MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

MLTX INVESTOR REMINDER: MoonLake Immunotherapeutics Investors may have been Affected by Fraud -- Contact BFA Law if You Suffered Losses

Nov 1, 2025, 7:08 AM EDT - 4 months ago

MLTX INVESTOR REMINDER: MoonLake Immunotherapeutics Investors may have been Affected by Fraud -- Contact BFA Law if You Suffered Losses

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Oct 28, 2025, 9:51 AM EDT - 4 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

ezequielsingh_90
ezequielsingh_90 Feb. 23 at 1:42 PM
$MLTX Think big scale, brother! Cutting peak demand 15–20% ain’t small potatoes - it’s structural uplift! 📈💥
0 · Reply
Warren_8
Warren_8 Feb. 23 at 1:39 PM
$MLTX
0 · Reply
ProteinAndProfits
ProteinAndProfits Feb. 23 at 1:39 PM
$MLTX Really appreciate Jorge’s explanation of labels, very interesting
1 · Reply
Ape_Of_WallStreet
Ape_Of_WallStreet Feb. 23 at 1:37 PM
$MLTX moon going to the moon
0 · Reply
Team_Zissou
Team_Zissou Feb. 23 at 1:36 PM
$MLTX Love Jorge specifically calling out the potential criticisms of one or two analysts at more than one point in his presentation. Don’t hold back Jorge, give ‘em hell!
1 · Reply
Cardwizard
Cardwizard Feb. 23 at 1:36 PM
$MLTX good information but nothing in the speech so far on the call that’s causing the stock to spike by any means,, unless Wall Street is just waiting for the bell to ring.
1 · Reply
HOWNOW
HOWNOW Feb. 23 at 1:34 PM
$MLTX 👆✅👍✊
0 · Reply
Bigpapa46
Bigpapa46 Feb. 23 at 1:33 PM
$MLTX Well my feed just crashed lol
1 · Reply
ParadiseProfit
ParadiseProfit Feb. 23 at 1:30 PM
$MLTX $FBIO $AIOS $IPW All low floats are going crazy! IBG could be next it seems!
0 · Reply
navyvet1234
navyvet1234 Feb. 23 at 1:29 PM
$MLTX Don't give up a single share.....be patient and HOLD what you have. It will pay off in spades in the end. Trust the science!!!!
0 · Reply
Shaybe16569
Shaybe16569 Feb. 23 at 1:27 PM
$MLTX
0 · Reply
Bigpapa46
Bigpapa46 Feb. 23 at 1:27 PM
$MLTX
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 23 at 1:25 PM
$MLTX (+7.7% pre) MLTX Stock Jumps Overnight As Spine Drug Trial Win Sets Stage For Investor Day Showdown https://ooc.bz/l/94223
0 · Reply
Bigpapa46
Bigpapa46 Feb. 23 at 1:20 PM
$MLTX This is Awesome!
0 · Reply
Bigpapa46
Bigpapa46 Feb. 23 at 1:19 PM
$MLTX
1 · Reply
ProfessionalTeamIntel
ProfessionalTeamIntel Feb. 23 at 1:19 PM
$MLTX Early-stage technology company
0 · Reply
Team_Zissou
Team_Zissou Feb. 23 at 1:19 PM
$MLTX I know the data is the star of this presentation but Kristian Reich is absolutely killing it. What a presenter!
0 · Reply
TheDizPlinTrader
TheDizPlinTrader Feb. 23 at 1:17 PM
$MLTX
0 · Reply
PikaPlays
PikaPlays Feb. 23 at 1:16 PM
$MLTX $SIDU $RCAT $BHAT --
0 · Reply
PikaPlays
PikaPlays Feb. 23 at 1:14 PM
$RZLV $NVTS $MLTX $UPST ++
0 · Reply
DanishViking92
DanishViking92 Feb. 23 at 1:14 PM
$MLTX this is ridiculous and laughable.. if this stock doesnt exceed $30 today, its a sucker..
1 · Reply
j_remy
j_remy Feb. 23 at 1:12 PM
$MLTX BLA acceptance now expected within 60 days of submission, I believe this is new news 👀
2 · Reply